◀ Back to MSH4

MSH4 — PLG

Text-mined interactions from Literome

Celis et al., Neurochem Int 1982 : Since PLG also blocked the release of MSH induced by the injection of haloperidol, it is suggested that its effect is not mediated by dopamine
Thody et al., Acta Endocrinol (Copenh) 1980 : We have studied the effect of L-prolyl-L-leucyglycinamide (PLG) on the release of melanocyte stimulating hormone ( MSH ) from the rat pituitary gland both in vitro and in vivo ... It is concluded that PLG does not affect the release of alpha-MSH from the rat intermediate lobe
Vivas et al., Neuroendocrinology 1982 : When 50 or 500 ng/ml of DA is added to the medium containing PLG concentrations it strengthened the inhibitory effect of PLG release, whereas the action of NE and PLG was additive ; at the highest tested concentration E ( 5,000 ng/ml ) blocked the inhibition of MSH induced by PLG
Scimonelli et al., Peptides 1982 : Both spontaneous and potassium induced release were inhibited in a dose-response manner by the tripeptide Pro-Leu-Gly-NH2 ( PLG, or MIF-1 ) ; 0.04 microgram to 1 microgram PLG inhibited the alpha-MSH release but the lowest dose demonstrated a greater inhibitory effect ; high concentrations of PLG, on the other hand, did not modify either spontaneous or potassium evoked alpha-MSH release from the slices
Caballero et al., J Endocrinol 1993 : When serum levels of progesterone were measured at 12.00 and 14.00 h in rats in which alpha-MSH release was blocked by PLG or concentrated antiserum, a significant decrease was observed when compared with the levels of progesterone in control rats